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Abstract
In the present study, the effects of subchronic per os exposures to cadmium chloride (CdCl2), and a carbamate
insecticide, propoxur (Pr), were investigated in male Wistar rats on general toxicological (body weight gain, relative
organ weights) haematological (RBC, WBC, Ht, MCV, cell content of the femoral bone marrow) immune function
(plaque forming cell (PFC) assay, delayed type hypersensitivity (DTH) reaction) and neurotoxicological (spontaneous
and stimulus-evoked cortical activity, nerve conduction velocity) parameters. The animals were treated for 4, 8 and
12 weeks with 6.43 mg/kg CdCl2, 8.51 mg/kg Pr, or with a combination of 6.43 mg/kg CdCl2+0.851 mg/kg Pr or
8.51 mg/kg Pr+1.61 mg/kg CdCl2. Cadmium exposure affected the relative thymus, liver, and adrenal weight, RBC
count, haematocrit and MCV, and there was an increase in nerve conduction velocity and a decrease in the cortical
evoked potential latency. Pr induced a decrease in thymus weight, had some effect on the liver weight but none on
the electrophysiological parameters. A significant interaction between Cd and Pr was detected by the following
parameters: RBC, Ht, PFC, and nerve conduction velocity. The results indicate that combined exposures in humans
may result in a shift in the apparent detection limits and/or in the LOEL of the single substances. The latter raises
the necessity to reconsider exposure limits in situations where the risk of combined exposure is high. © 2002 Elsevier
Science Ireland Ltd. All rights reserved.
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1. Introduction
Widespread application of propoxur (Pr) in
insect control and households (and, to a lesser
extent, in agriculture) in many countries in-
evitably results in exposure of the population to
higher (producers, distributors, hygienic workers)
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or lower (households) levels. As a member of the
carbamate insecticides (WHO/IPCS, 1986), Pr is
designed to be neurotoxic, with massive reversible
inhibition of acetylcholinesterase as the main
mechanism of action (Alvares, 1992). In rats, a
single dose of ca. 1/10 LD50 caused a 60% drop in
cholinesterase activity and marked disturbances in
higher nervous functions (Thiesen et al., 1999).
Immunomodulating effects of 8.51 mg/kg Pr ad-
ministered to rats per os for 4 weeks also have
been demonstrated in our earlier studies (Siroki et
al., 2001; Instito´ris et al., 2001a).
When considering the present status of the envi-
ronment, it can be stated that any environmental
exposure of the population will be multiple. Cad-
mium, one of the heavy metals often present in
polluted areas, can be emitted during the produc-
tion and use of the metal (mining, smelting, dry
cell manufacturing etc.) and from disposal of
cadmium containing waste, including used cells
and sludge (Elinder, 1985). Some food products
(e.g. cereals; Mu¨ller and Anke, 1994) and tobacco
smoke are also major sources of human exposure
(Elinder, 1985).
The most important target organs of cadmium
toxicity are the kidneys, the bones, the respiratory
and cardiovascular systems (WHO/IPCS, 1992).
In addition, cadmium exposure can also cause
behavioural and neurological disorders. Repeated
doses of cadmium administered to rats for 9 days
caused epileptiform EEG activity (Vataev et al.,
1994). In children exposed to Cd, effects on higher
nervous functions, such as lowered IQ (Thatcher
et al., 1982) or behavioural abnormalities (Mar-
lowe et al., 1985) were observed. In rats exposed
to Cd before and/or after birth, locomotor (Smith
et al., 1985; Ruppert et al., 1985) and behavioural
(Mohd et al., 1986) development was affected. In
our previous works, alterations of spontaneous
and evoked cortical electrical activity were found
(Nagymajte´nyi et al., 1997). Cadmium also influ-
ences the metabolism of acetylcholine (Devi and
Fingerman, 1995) and of biogenic amines (Flora
and Tandon, 1987) in the brain.
The literature on the immunomodulating effects
of Cd is controversial. Exon et al. (1986) de-
scribed increased resistance to viral infection fol-
lowing intermediate duration oral exposure to
cadmium. In other experiments, a similar dose
resulted in increased mortality from virally in-
duced leukemia (Blakley, 1986; Malave´ and de
Ruffino, 1984).
In case of combined or multiple exposures,
interactions are of special importance. According
to Groten et al. (1997), the exposure of rats with
different combinations in NOEL (Non Observed
Effect Level) doses of nine environmental chemi-
cals resulted in significant toxicological alter-
ations. In rats exposed to arsenic– lead
combinations, significant changes were detected in
the central monoaminogenic system. These alter-
ations were absent when the animals were treated
with the same doses of each metal (Mejia et al.,
1997). Depending on the doses, different interac-
tions were found between PCB 153 and TCDD in
the plaque forming cell (PFC) response to sheep
red blood cells (SRBC) in mice (Smialowicz et al.,
1997). Combined exposure with trichotecenes re-
sulted in both antagonistic and additive effects on
the lymphoproliferative response and antibody
production of human lymphocytes in vitro (Thu-
vander et al., 1999).
Interactions between pesticides and heavy
metals have also been observed in our earlier
immunotoxicity studies in rats following 28 days
of combined oral exposures (Instito´ris et al.,
1999a,b, 2001a,b). The main issue raised by these
studies is whether NOEL doses of heavy metals
can modify the toxic effects of the LOEL (Lowest
Observed Effect Level) doses of pesticides, and
vice versa. Using an immunotoxicological proto-
col based on OECD Guideline 407 (Instito´ris et
al., 1998), the dose–effect curves of the substances
examined were determined following 28 days of
oral exposure (Instito´ris et al., 1995, 1999c; Siroki
et al., 2001; U ndeger et al., 2000). The lowest dose
which produces a statistically significant alteration
in at least one of the parameters examined in
these experiments was defined as the LOEL, and
the dose inducing no effect according to the above
criteria as the NOEL. The same protocol, includ-
ing general toxicological, haematological and im-
mune function parameter investigations, was
subsequently used in the combination studies. In
these studies, the LOEL doses of pesticides (High
dose, H) were combined with the NOEL doses
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(Low dose, L) of heavy metals, and vice versa, in
order to reveal synergistic or antagonistic effects
(Instito´ris et al., 1999a,b, 2001a; U ndeger et al.,
2000).
The aims of the present study were: (1) to show
whether the extension of the exposure period re-
sulted in new changes of the parameters studied;
and (2) to compare the predictability of the inter-
actions using conventional toxicological and
haematological parameters as well as immune
function assays, and neurophysiological methods.
2. Materials and methods
2.1. Materials and animals
Pr (isopropoxiphenylmethylcarbamate) of
99.4% purity was a gift from Bayer AG, Ger-
many. Lyophilised complement, Freund’s Com-
plete Adjuvant (FCA) and SRBC were obtained
from HUMAN Inst., Budapest, Hungary; RPMI-
1640, from SIGMA, USA; Keyhole Limpet
Haemocyanin (KLH), from Calbiochem, USA.
The other materials were supplied by REANAL
Factory of Laboratory Chemicals, Budapest,
Hungary.
In all experiments, 6–7 weeks old male outbred
Wistar rats (originating from the SPF breed of
Research Institute of Laboratory Animals,
Go¨do¨llo¨, Hungary) were used. The animals were
kept under conventional conditions (up to five
rats per cage, 12 h light–dark cycle, 222 °C,
7010% humidity), standard rodent food and
water were available ad libitum. Pr was dissolved
in sunflower oil of pharmaceutical quality, and
CdCl2 (Cd) in distilled water, and were given by
gavage in a volume of 2.0 (Pr) or 5.0 (Cd) ml/kg.
2.2. Experimental design
According to earlier results (Siroki et al., 2001;
Instito´ris et al., 1999b) the applied doses of Pr
were Pr(H) LOEL=8.51 and Pr(L) NOEL=
0.851 mg/kg, those of CdCl2 Cd(H) LOEL=6.43
and Cd(L) NOEL=1.61 mg/kg. The combina-
tions of Pr and Cd are shown below. Groups of
animals received the higher dose of Pr or Cd and
one control group was given the vehicle.
Combinations
Group 1 Pr(H)+Cd(L)
Pr(H)Group 2
Cd(H)+Pr(L)Group 3
Group 4 Cd(H)
Vehicle controlGroup 5
Groups of 24 rats per dose were divided into
three subgroups and were treated according to the
above scheme for 4, 8 and 12 weeks. Eight ani-
mals were used for toxicological and haematologi-
cal examinations, eight for PFC assay, and eight
for delayed type hypersensitivity (DTH) reaction
and neurotoxicological investigations. The neuro-
toxicological parameters were measured 4 days
after challenge of the DTH reaction.
2.3. Parameters examined
2.3.1. Toxicological and haematological
parameters
The body weight was measured once a week.
The weight of the brain, thymus, lung, heart,
liver, spleen, kidneys, adrenals, testicles, and
popliteal lymph node was measured on the day of
termination of the study (29th, 57th, and 85th
days). Blood for haematological studies was taken
from the abdominal aorta of the same animals.
Absolute white blood cell (WBC) count, red
blood cell (RBC) count, haematocrit (Ht), mean
cell volume of RBC-s (MCV), and the cell content
of the femoral bone marrow were determined by a
PS-5 Blood Cell Counter (Medicor, Budapest,
Hungary). The cellularity of the bone marrow was
counted from one of the femurs as described
earlier (Instito´ris et al., 1995).
2.3.2. IgM-PFC assay
The animals were immunised by 2×109 SRBC
i.p. in 0.4 ml PBS 4 days prior to termination.
Then, the spleen was removed and the IgM-PFC
number, calculated for 106 spleen cells and for the
whole spleen, was determined (Instito´ris et al.,
1995).
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2.3.3. Delayed type hypersensitiity
The animals were immunised s.c. at the base of
the tail by 1 mg KLH in 0.4 ml antigen prepara-
tion (KLH dissolved in sterile PBS and emulgated
by equal volume of FCA) 14 days prior to chal-
lenge. The reaction was challenged by injecting
17.5 g KLH in 50 l PBS into the left hind
footpad. Footpad thickness was measured just
before, 24, and 48 h after challenge by a Mi-
crostat micrometer (Cadar, UK), and specific
footpad swelling (D%) was calculated as de-
scribed earlier (Instito´ris et al., 1995).
2.4. Neurotoxicological parameters
Spontaneous and stimulus-evoked cortical ac-
tivity was recorded from the animals in acute
preparation. One day after the last treatment (and
4 days after DTH challenge, see above) the rats
were anaesthetised with urethane (1000.0 mg/kg
i.p.; Bowman and Rand, 1980); and placed in a
stereotaxic frame. The left hemisphere was ex-
posed by opening the skull, and ball-tipped silver
wire electrodes were placed on the primary so-
matosensory (Par1), visual (Oc1B) and auditory
(Te1) cortical areas (after Zilles, 1982). Following
a recovery period of ca. 30 min, simultaneous
electrocorticogram (ECoG) was recorded for 5
min. Sensory evoked potentials were thereafter
recorded from the same sites. For somatosensory
stimulation, a pair of needles was inserted be-
tween the contralateral whiskers, and fine electric
shocks (1 Hz, 3–4 V, 0.2 ms) were delivered. For
visual stimulation, flashes (1 Hz, 60 lux) of a
flashbulb were directed to the contralateral eye via
an optical conductor. Clicks (1 Hz, 40 dB) were
used for acoustic stimulation, through the hollow
ear bar into the contralateral ear of the rat.
Recording and stimulation of the activities was
performed by a Neurosys (Experimetria Ltd.,
UK) system. The ECoG analysis provided the
frequency power spectrum by bands and the
ECoG index (activity of the delta+ theta bands
divided by that of the beta1+beta2 bands). In
case of cortical evoked responses, 50 potentials of
each modality were averaged, and latency and
duration of the main waves was measured
manually.
The tail nerve was used to test the functioning
of the peripheral nervous system. Nerve conduc-
tion velocity was measured as already described
(Miyoshi and Goto, 1973) with minor modifica-
tions. Relative and absolute refractory periods
were calculated (Anda et al., 1984).
When recordings were completed, an overdose
of urethane was administered and the animals
were dissected. The brain, liver, heart, lung, kid-
neys, thymus, and adrenal glands were weighed,
and organ weights, relative to the brain weight,
were calculated.
The whole study was performed in strict adher-
ence to the principles by the Ethical Committee
for Protection of Animals in Research of the
University.
2.5. Statistical analysis
Data were checked for normality of distribution
by the Kolmogorov–Smirnov test. Depending on
the distribution, the statistical analyses were car-
ried out by ANOVA or Kruskal–Wallis non-
parametric ANOVA (P0.05). Post hoc analysis
of group differences was performed by LSD test
(P0.05).
3. Results
Neither macroscopic alterations during dissec-
tion of the animals nor changes in their behaviour
during treatment were observed. A delay in body
weight gain appeared from the 4th or 6th weeks
onward in the groups treated with the Pr(H)+
Cd(L) or Cd(H)+Pr(L) combinations. The differ-
ence from the vehicle control group was −8% in
both cases on the 12th week.
The changes in relative organ weights are pre-
sented in Table 1. After 8 or 12 weeks of treat-
ment with Pr or Cd, and their combinations, the
relative thymus weight was decreased. Increased
relative liver weight was observed on the 4th week
in the Pr(H)+Cd(L) and Pr(H) groups, but an
opposite change was observed on the 8th week in
the same groups. Significant interactions were de-
tected only by changes in relative adrenal weight.
Treatment with Pr(H)+Cd(L) (but not Pr(H)
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alone) induced increase in the relative adrenal
weight on the 4th and 12th weeks. On the 12th
week, Cd(H) decreased the relative adrenal
weight, but the combination with Pr(L), Cd(H)
resulted in a significant increase.
Among the haematological parameters mea-
sured (Table 2) Pr(H) significantly reduced the
RBC count and the Ht value on the 4th week, but
the combination Pr(H)+Cd(L) had no effect. On
the 8th and 12th weeks, the same parameters were
significantly increased by Cd(H) but not by the
Cd(H)+Pr(L) combination. On the 12th week,
Cd(H) also increased the cell content of the
femoral bone marrow and MCV, but neither of
these parameters differed from the vehicle control
when Cd(H) was combined with Pr(L).
Both combinations and Pr(H) alone signifi-
cantly decreased the PFC response on the 4th and
8th weeks, while Cd(H) resulted in an increased
response on the 8th week (Table 3). On the 12th
Table 1
Effect of treatment with Cd, Pr, and with their combinations on the relative organ weights
Organ weight to 100 g body weight Organ weight to brain (g/g)DosesCompounds
(mg/kg) (4 weeks treatment) (4 weeks treatment)
Liver Adrenalsa Thymus Liver AdrenalsaThymus
Prb 0.3510.02H=8.51 7.560.18** 27.81.120.2840.01 4.930.07* 18.10.07c
L=0.851 27.40.846.700.150.2340.01 0.3540.0218.20.074.430.08
26.60.946.610.240.3740.0117.50.064.340.070.2470.01Control
0.3500.02 6.890.18 28.91.19CdCl2
b H=6.43 0.2420.02 4.780.08* 20.00.63*
6.390.14 25.51.00L=1.61 0.2440.01 4.490.11 17.80.55 0.3500.02
Control 0.2310.01 25.50.6616.80.48 6.190.664.060.17 0.3540.02
CombinationsWeeks of
treatment
0.3120.0416.30.54*,c4.500.07* 24.82.610.1800.01Pr(H)+Cd(L)4 7.750.67
7.000.21Pr(H) 19.01.070.1820.01 4.290.10* 13.70.78 0.2960.02
0.2450.03*Cd(H)+Pr(L) 6.120.22 18.20.930.1600.02 4.010.10 13.90.59
0.2110.02* 5.620.19**Cd(H) 17.91.680.1450.01 3.890.09 13.41.05
0.1790.01 20.21.186.690.250.3150.0213.50.663.820.12Control
8 0.1260.01*Pr(H)+Cd(L) 28.71.563.920.06* 6.560.200.2830.0212.80.82
Pr(H) 28.91.936.310.27*0.2750.023.810.08*0.1220.01* 12.90.85
14.10.684.170.180.1190.01* 0.2630.02*Cd(H)+Pr(L) 7.020.17 31.31.79
0.2530.02* 6.730.38 33.42.02Cd(H) 0.1160.01* 4.060.08* 15.30.95
13.70.81Control 0.3210.02 7.220.38 28.61.410.1550.01 4.430.13
16.60.56*Pr(H)+Cd(L) 0.2280.02* 6.670.28 37.71.26*,c0.0960.01* 3.810.090
30.11.636.900.260.1800.01*12.91.013.910.050.0770.01*Pr(H)
17.00.91*,cCd(H)+Pr(L) 0.2390.07 6.870.28 39.21.99*, c c0.1030.01* 3.970.0812
Cd(H) 0.0960.01* 3.740.06 12.50.54 28.51.080.2180.01 6.260.17
14.50.773.860.080.1210.01Control 34.71.937.070.330.2970.02
Pr(H), the High (LOEL) dose; Pr(L), the Low (NOEL) dose of Pr; Cd(H) and Cd(L) are the LOEL and NOEL doses of CdCl2.
* P0.05; **P0.01 compared to vehicle control.
c P0.05; c cP0.01 compared to the high dose internal control.
a Relative adrenal weights are expressed as mg/100 g body weight or mg/g brain weight.
b Results of preliminary experiments.
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Table 2
Changes of certain haematological parameters following 4, 8 and 12 weeks treatment with Cd, Pr and with their combinations
Compounds Haematological parameters (4 weeks treatment)Doses (mg/kg)
RBC (×109/ml)) Ht (%) MCV (fl) Cell/femur (×108)
6.770.16 56.41.14*Pra 83.61.13*H=8.51 2.060.12*
6.940.14 61.71.39* 88.91.10*L=0.851 1.710.09
6.500.17 49.03.24 74.92.99Control 1.470.09
6.680.14 41.40.10* 61.90.60* 1.480.09CdCl2
a H=6.43
6.910.35 44.90.89*L=1.61 65.10.26* 1.650.03
Control 7.130.21 49.21.22 69.40.52 1.640.08
Weeks of treatment Combinations
4 5.990.18cPr(H)+Cd(L) 43.10.87c 75.20.74 2.290.14
Pr(H) 5.470.16* 38.81.09* 72.71.12 2.030.10
6.000.15 42.30.77Cd(H)+Pr(L) 73.80.65 2.260.12
5.940.13 41.00.93 72.21.03Cd(H) 2.030.13
6.400.17 44.11.27Control 73.20.96 2.080.19
8 Pr(H)+Cd(L) 7.960.29 40.01.33 70.40.61 1.780.15
8.360.34 41.81.64Pr(H) 70.10.44 1.860.09
8.320.17c 42.10.62c 70.50.47Cd(H)+Pr(L) 1.810.14
9.170.28* 50.21.37*Cd(H) 70.20.38 1.460.15
8.210.29 41.01.41 69.90.48Control 1.860.18
6.460.32 46.41.04Pr(H)+Cd(L) 68.00.83*12 1.900.36
6.490.24 44.01.58 68.60.36*Pr(H) 1.400.13
7.380.07*,c 60.20.48cCd(H)+Pr(L) 68.90.27c 1.330.14c
8.940.31* 73.93.25* 76.73.03*Cd(H) 2.930.23*
6.700.08 46.40.63Control 71.20.46 1.680.20
Pr(H), the High (LOEL) dose; Pr(L), the Low (NOEL) dose of Pr; Cd(H) and Cd(L) are the LOEL and NOEL doses of CdCl2.
* P0.05, compared to vehicle control.
c P0.05, compared to the high dose internal control.
a Results of preliminary experiments.
week, Pr(H) and Cd(H) decreased the PFC re-
sponse, but their combinations with Cd(L) or
Pr(L) induced increases.
Each combination and also the high dose of Pr
and Cd significantly decreased the DTH reaction
on the 4th and 12th weeks (Table 4).
The neurotoxicological effects were minimal af-
ter 4 and 8 weeks and not very marked after 12
weeks either. In the spontaneous activity, high
dose Cd, alone and combined with low dose Pr,
caused a slight increase in the slow wave and a
decrease in the fast wave activity, corresponding
to an increase of the ECoG index, in the auditory
focus (Fig. 1). In the two other areas, the ECoG
index was decreased. Pr(H) and Pr(H)Cd(L) treat-
ment caused a small, not significant decrease in
the index, in the somatosensory and a slight in-
crease in the visual and auditory foci.
In the stimulus-evoked cortical activity, the
general trend was a shortening of the onset la-
tency of the EPs. This was less pronounced in the
somatosensory focus and more in the two others.
The effect was most pronounced with Cd(H)
treatment and was in some cases significant (Fig.
2). No effect was seen on the duration of the
potentials. The somatosensory and auditory EPs
showed some decrease and the visual ones an
increase which mostly remained insignificant. On
the latency of the somatosensory EP, the
Cd(H)+Pr(L) combination was more effective
than Cd(H). On the visual EP, the Pr(H)+Cd(L)
combination, and on the auditory EP, both
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Pr(H)+Cd(L) and Cd(H)+Pr(L) combinations
had a stronger effect than the high dose compo-
nent of the corresponding combinations alone.
The most affected parameter of peripheral
nerve function was the conduction velocity, which
was significantly increased by all treatments con-
taining Cd (Fig. 3). The changes of the relative
and absolute refractory periods were much more
scattered, but there was a general trend of short-
ening, significant only with the Pr(H)+Cd(L)
combination.
4. Discussion
There is only a limited number of data in the
literature which are directly comparable with the
results of the present experiments. Retardation in
body weight gain has been demonstrated in mice
exposed to 50 or 200 ppm Cd in the drinking
water for 3 weeks or longer (Malave´ and de
Ruffino, 1984). Histological changes were ob-
served in the liver of Wistar rats, following a
single oral 32.5 mg/kg dose of CdCl2 (Vojtisek et
al., 1989). Decreased thymus and increased spleen
weight have been described in mice treated with 1
mg/kg Cd s.c. for 5 days (Ohsawa et al., 1983).
Following subacute oral treatment of rats with
0.8–5.8 mg/kg cadmium, diminished haematocrit,
lower RBC count and anaemia were found and
these changes seemed to be dose-, treatment time-,
gender-, and strain-dependent (ATSDR, 1999).
Table 3
Effect of 4, 8 and 12 weeks treatment with Cd, Pr and with their combinations on the IgM-PFC content of the spleen
PFC assay (4 weeks treatment)Compounds Doses (mg/kg)
PFC/106 ×103 PFC/spleen ×106Spleen cells ×108
7.680.04 2.000.19*Pra 1.520.01*H=8.51
L=0.851 7.760.07 3.260.44 2.650.05
6.770.03 4.170.35 2.790.02Control
CdCl2
a 1.530.272.420.276.390.40H=6.43
6.680.33L=1.61 2.430.41 1.640.31
6.580.33 3.270.41 2.150.31Control
Weeks of treatment Combinations
4 Pr(H)+Cd(L) 12.11.25 3.580.47* 4.160.46
4.200.423.940.11*10.61.02Pr(H)
Cd(H)+Pr(L) 9.550.71 4.000.29* 3.870.44
Cd(H) 9.900.66 4.490.38 4.470.55
10.50.17 5.220.25 5.380.85Control
Pr(H)+Cd(L) 7.940.498 2.470.29* 1.900.14*
Pr(H) 8.800.67 2.030.09* 1.790.16*
Cd(H)+Pr(L) 11.21.17 2.540.34 3.010.67
Cd(H) 7.230.64 3.410.48 2.410.35
Control 8.930.84 3.160.15 2.810.26
1.880.24c2.010.17c9.471.17Pr(H)+Cd(L)12
Pr(H) 9.941.32 1.190.19* 1.070.11
1.740.25c2.010.1*,c8.540.99Cd(H)+Pr(L)
1.170.177.540.69 0.940.21Cd(H)
Control 8.150.88 1.850.14 1.530.23
Pr(H), the High (LOEL) dose; Pr(L), the Low (NOEL) dose of Pr; Cd(H) and Cd(L) are the LOEL and NOEL doses of CdCl2.
* P0.05, to vehicle control.
c P0.05, compared to the high dose internal control.
a Results of preliminary experiments.
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Table 4
Changes of DTH reaction detected by footpad swelling assay following 4, 8 and 12 weeks treatment with Cd, Pr and with their
combinations
Compounds Specific footpad thickness (%) (4 weeks treatment)Doses (mg/kg)
24 h 48 h
19.82.33Pra 11.01.17H=8.51
17.61.71 11.21.82L=0.851
22.02.90 14.92.97Control
CdCl2
a 11.03.5*H=6.43 8.121.6*
19.71.8L=1.61 12.40.9
Control 24.43.1 14.42.0
CombinationsWeeks of treatment
Pr(H)+Cd(L)4 17.62.75 11.02.55
Pr(H) 15.15.07* 8.283.03
13.72.73*Cd(H)+Pr(L) 9.491.63*
13.72.10* 8.192.36*Cd(H)
28.21.94Control 15.72.10
8 20.73.85Pr(H)+Cd(L) 11.42.69
16.42.58Pr(H) 10.62.54
Cd(H)+Pr(L) 17.83.11 11.81.73
Cd(H) 17.23.14 13.12.96
19.91.29Control 11.91.42
Pr(H)+Cd(L)12 10.41.55* 6.231.44
10.10.77*Pr(H) 5.440.70
14.31.14* 6.391.23Cd(H)+Pr(L)
13.31.51*Cd(H) 8.611.69
20.21.17 8.951.08Control
Pr(H), the High (LOEL) dose; Pr(L), the Low (NOEL) dose of Pr, Cd(H) and Cd(L) are the LOEL and NOEL doses of CdCl2.
* P0.05, compared to vehicle control.
a Results of preliminary experiments.
Among the toxicological and haematological
parameters investigated in the present study, Cd
exposure affected the relative thymus, liver, and
adrenal weight, RBC count, haematocrit and
MCV.
Conflicting results (but mainly immunosuppres-
sion) have been published on the effects of Cd on
the humoral immune response. Cell mediated im-
munity, on the contrary, is consistently depressed
(Descotes, 1986). In accordance with these results,
we saw a decrease in the DTH reaction, whereas
the humoral immune response (PFC assay) did
not change.
In spite of low permeability across the blood–
brain barrier, Cd was described to accumulate in
various parts of the rat brain after oral exposure
to a dose similar to the Cd(H) of the present work
(Clark et al., 1985). Several toxic effects of Cd
have been described in neurons. Cd has been
shown to influence the metabolism of
monoamines (Hobson et al., 1986; Flora and Tan-
don, 1987) and acetylcholine (Devi and Finger-
man, 1995). Through its well-known blocking
effect on calcium channels, Cd can affect trans-
mitter release (Soliakov and Wonnacott, 1996) or
other calcium regulated phenomena. The effects
on monoamines and acetylcholine, modulators of
cortical activity, can explain the mild alterations
found in the ECoG in our experiments. With
higher Cd doses (up to 14 mg/kg) and using a
different treatment schedule (pre/postnatal), more
marked alterations of the spontaneous cortical
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activity, expressed as a shift to higher frequencies,
have been found (Nagymajte´nyi et al. (1997). Our
different results are probably due to the age-de-
pendent difference in rat metallothionein levels
(Goering and Klaassen, 1984) and, hence, the
neutralisation capacity. The effect of Cd on
synaptic transmission and cortical modulation
may also explain alterations seen in sensory
evoked potentials. Cd is known to affect nerves
themselves (Sato et al., 1978). The increase in
nerve conduction velocity on Cd treatment could
possibly contribute to the latency change of the
cortical evoked potentials.
Higher doses of Pr (3000 and 6000 ppm in diet,
corresponding to ca. 25 and 50 mg/kg/day, re-
spectively) resulted in retarded body weight gain,
and in increased relative liver, lung and kidney
weight in the rat (WHO/FAO Working Groups,
1989). In the present study, 8.51 mg/kg Pr in-
duced a decrease in thymus weight and had a
treatment-time dependent effect on the liver
weight. Concomitant changes in the haematologi-
cal parameters were not observed. No data could
be found in the literature relevant to the im-
munomodulatory effect of Pr in this dose range.
Similarly to the present results, however, de-
creased PFC response was observed in our two
previous experiments in 4-week-old rats following
administration of 8.51 mg/kg Pr for 4 weeks
(Instito´ris et al., 2001a; Siroki et al., 2001).
The primary nervous system effect of Pr, as
that of other carbamate insecticides, is an inhibi-
tion of acetylcholinesterase (WHO/IPCS, 1986;
Krechniak and Foss, 1982). In spite of that, it has
been described that the effects of Pr on higher
nervous activity and cholinesterase activity show a
different time course (Ruppert et al., 1985). More-
over, subacute Pr treatment had an atropine-like
effect on intestinal cholinergic activity (Kobayashi
et al., 1994). Comparing our findings to earlier
ones with different organophosphates (De´si and
Nagymajte´nyi, 1999; Nagymajte´nyi et al., 1994),
the effect of Pr and organophosphates appear
dissimilar. Another mechanisms to be taken into
consideration is the effect of Pr on ATP-depen-
dent ionic balance and primarily on calcium
(Babu et al., 1990). The resulting synaptic dys-
function may explain the alterations of sponta-
neous and evoked cortical activity.
The examined general toxicological, haemato-
logical and immune function parameters which
showed a significant change both on exposure
with the single substances and their combinations
are summarised in Tables 1–4. Electrophysiologi-
Fig. 1. ECoG indexes in the three cortical foci (A, somatosensory; B, visual; C, auditory) in the control and treated groups after
12 weeks treatment (XS.E., n=8). Group labels (abscissa) are as in the text; for definition of ECoG index, see Section 2.
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Fig. 2. Latency (left bars) and duration (right bars) of sensory evoked potentials from the three cortical foci in the control and
treated groups after 12 weeks treatment (XS.E., n=8). *P0.05, to vehicle control; cP0.05, to internal control.
cal parameters meeting the same criterion are
given in Figs. 2 and 3. It can be generally stated
that most alterations were more and more intense
with prolonging treatment duration. A significant
interaction between Cd and Pr was detectable on
body weight gain (8th week), RBC (4th, 8th, 12th
week), Ht (4th, 8th, 12th week) MCV (12th week)
and femur cellularity (12th week). In these para-
L. Instito´ris et al. / Toxicology 178 (2002) 161–173 171
meters, the significant effect of the high dose
substance was significantly diminished or even
reversed by the low dose of the other. As shown
by the time data, RBC count and Ht seemed to be
the most sensitive indicators because they detected
an interaction as early as the 4th week. In the
Fig. 3. Parameters of the tail nerve action potential in the control and treated groups after 12 weeks treatment (XS.E., n=8).
*P0.05, to vehicle control; cP0.05, to internal control.
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immune function assays, the effect of Pr, Cd and
combinations were mostly significant at all treat-
ment periods, but the PFC assay was the only
assay indicating significant interactions on the
12th week. As regards the electrophysiological
parameters, the effect of Pr was minimal. On the
12th week, significant changes were caused—only
by high dose Cd or one of the combinations—on
the latency of the sensory evoked potentials and
on the nerve conduction velocity. There was, how-
ever, no clear interaction trend.
Our results do not show a clean interaction
between Pr and Cd. At the cellular level, and first
of all in the nervous system, Pr and Cd have
common targets and mechanisms of action, e.g.
disturbance of Ca homeostasis. The interaction is
more likely kinetic. Our dosing regime do not
allow direct animal-to-human extrapolation. It
cannot be excluded that multiple human exposure
with these agents involve a shift in the apparent
LOAELs. It remains to be determined whether
safety limits determined with a single substance is
inadequate in case of combined exposures.
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